Mesoporous tantalum oxide nanomaterials induced cardiovascular endothelial cell apoptosis via mitochondrial-endoplasmic reticulum stress apoptotic pathway. (31st December 2023)
- Record Type:
- Journal Article
- Title:
- Mesoporous tantalum oxide nanomaterials induced cardiovascular endothelial cell apoptosis via mitochondrial-endoplasmic reticulum stress apoptotic pathway. (31st December 2023)
- Main Title:
- Mesoporous tantalum oxide nanomaterials induced cardiovascular endothelial cell apoptosis via mitochondrial-endoplasmic reticulum stress apoptotic pathway
- Authors:
- Jiao, Yuanyong
Zhang, Xiwei
Yang, Hongyu
Ma, Hao
Zou, Junjie - Abstract:
- Abstract: Along with its wide range of potential applications, human exposure to mesoporous tantalum oxide nanomaterials (PEG@mTa2 O5 ) has substantially risen. Accumulative toxic investigations have shown the PEG@mTa2 O5 intake and cardiovascular diseases (CVD). Endothelial cell death is crucial in the onset and development of atherosclerosis. Still, the molecular mechanism connecting PEG@mTa2 O5 and endothelium apoptosis remains unclear. Herein, we studied the absorption and toxic action of mesoporous tantalum oxide (mTa2 O5 ) nanomaterials with polyethylene glycol (PEG) utilizing human cardio microvascular endothelial cells (HCMECs). We also showed that PEG@mTa2 O5 promoted apoptosis in endothelial cells using flow cytometry and AO-EB staining. In conjunction with the ultrastructure modifications, PEG@mTa2 O5 prompted mitochondrial ROS production, cytosolic Ca 2+ overload, ΔΨm collapse, and ER stress verified by elevated ER-Tracker staining, upregulated XBP1 and GRP78/BiP splicing. Remarkably, the systemic toxicity and blood compatibility profile of PEG@mTa2 O5 can greatly improve successive therapeutic outcomes of NMs while reducing their adverse side effects. Overall, our findings suggested that PEG@mTa2 O5 -induced endothelium apoptosis was partially mediated by the activation of the endoplasmic reticulum stress-mitochondrial cascade.
- Is Part Of:
- Drug delivery. Volume 30:Number 1(2023)
- Journal:
- Drug delivery
- Issue:
- Volume 30:Number 1(2023)
- Issue Display:
- Volume 30, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 30
- Issue:
- 1
- Issue Sort Value:
- 2023-0030-0001-0000
- Page Start:
- 108
- Page End:
- 120
- Publication Date:
- 2023-12-31
- Subjects:
- Tantalum oxide -- HCMECs -- apoptosis -- mitochondria -- endoplasmic reticulum -- animal model
Drug delivery systems -- Periodicals
Drug targeting -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/drd ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10717544.2022.2147251 ↗
- Languages:
- English
- ISSNs:
- 1071-7544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.104600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24717.xml